These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15327616)

  • 21. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.
    Ashok PW; Templeton A; Wagaarachchi PT; Flett GM
    BJOG; 2002 Nov; 109(11):1281-9. PubMed ID: 12452467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T; Winikoff B
    BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Misoprostol for second trimester pregnancy termination in women with prior caesarean section.
    Daskalakis GJ; Mesogitis SA; Papantoniou NE; Moulopoulos GG; Papapanagiotou AA; Antsaklis AJ
    BJOG; 2005 Jan; 112(1):97-9. PubMed ID: 15663405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acceptability of home medical abortion to women in UK settings.
    Hamoda H; Critchley HO; Paterson K; Guthrie K; Rodger M; Penney GC
    BJOG; 2005 Jun; 112(6):781-5. PubMed ID: 15924537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of combination RU 486-laminaria tents-misoprostol-peridural anesthesia in second and third trimester induced abortions].
    Hoffer MC; Charlier C; Giacalone PL; Zimbris L; Astruc M; Boulot P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Jan; 27(1):83-6. PubMed ID: 9583050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
    Singh KC; Ummat S; Rajaram S; Goel N
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mifepristone in second-trimester medical abortion: a randomized controlled trial.
    Kapp N; Borgatta L; Stubblefield P; Vragovic O; Moreno N
    Obstet Gynecol; 2007 Dec; 110(6):1304-10. PubMed ID: 18055725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days.
    Schreiber CA; Creinin MD; Harwood B; Murthy AS
    Contraception; 2005 Jun; 71(6):447-50. PubMed ID: 15914135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion.
    Borgatta L; Chen AY; Vragovic O; Stubblefield PG; Magloire CA
    Contraception; 2005 Nov; 72(5):358-61. PubMed ID: 16246662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities.
    Lo TK; Lau WL; Lai FK; Lam H; Tse HY; Leung WC; Chin RK
    Prenat Diagn; 2008 Jun; 28(6):508-11. PubMed ID: 18509869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.